Stereotactic Radiosurgery in the Management of Brain Metastases: A Case-Based Radiosurgery Society Practice Guideline.


Journal

Advances in radiation oncology
ISSN: 2452-1094
Titre abrégé: Adv Radiat Oncol
Pays: United States
ID NLM: 101677247

Informations de publication

Date de publication:
Mar 2024
Historique:
received: 07 08 2023
accepted: 17 10 2023
medline: 31 1 2024
pubmed: 31 1 2024
entrez: 31 1 2024
Statut: epublish

Résumé

Brain metastases are common among adult patients with solid malignancies and are increasingly being treated with stereotactic radiosurgery (SRS). As more patients with brain metastases are becoming eligible for SRS, there is a need for practical review of patient selection and treatment considerations. Two patient cases were identified to use as the foundation for a discussion of a wide and representative range of management principles: (A) SRS alone for 5 to 15 lesions and (B) a large single metastasis to be treated with pre- or postoperative SRS. Patient selection, fractionation, prescription dose, treatment technique, and dose constraints are discussed. Literature relevant to these cases is summarized to provide a framework for treatment of similar patients. Treatment of brain metastases with SRS requires many considerations including optimal patient selection, fractionation selection, and plan optimization. Case-based practice guidelines developed by the Radiosurgery Society provide a practical guide to the common scenarios noted above affecting patients with metastatic brain tumors.

Identifiants

pubmed: 38292892
doi: 10.1016/j.adro.2023.101402
pii: S2452-1094(23)00230-0
pmc: PMC10823095
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

101402

Informations de copyright

© 2023 Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.

Auteurs

Colton Ladbury (C)

Department of Radiation Oncology, City of Hope National Medical Center, Duarte, California.

Michael Pennock (M)

Department of Radiation Oncology, Montefiore Einstein Cancer Center, Bronx, New York.

Tugba Yilmaz (T)

Department of Radiation Oncology, Necmettin Erbakan University Meram Medical Faculty Hospital, Konya, Turkey.

Nii-Kwanchie Ankrah (NK)

Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama.

Therese Andraos (T)

Department of Radiation Oncology, The Ohio State University James Cancer Hospital, Columbus, Ohio.

Emile Gogineni (E)

Department of Radiation Oncology, The Ohio State University James Cancer Hospital, Columbus, Ohio.

Grace Gwe-Ya Kim (GG)

Department of Radiation Oncology, University of California San Diego, San Diego, California.

Iris Gibbs (I)

Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California.

Helen A Shih (HA)

Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts.

Jona Hattangadi-Gluth (J)

Department of Radiation Oncology, University of California San Diego, San Diego, California.

Samuel T Chao (ST)

Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio.

Susan C Pannullo (SC)

Department of Neurological Surgery, New York Presbyterian Hospital and Weill Cornell Medicine, New York, New York.

Ben Slotman (B)

Department of Radiation Oncology, Amsterdam UMC, Amsterdam, Netherlands.

Kristin J Redmond (KJ)

Department of Radiation Oncology, Johns Hopkins Medicine, Baltimore, Maryland.

Simon S Lo (SS)

Department of Radiation Oncology, University of Washington, Seattle, Washington.

Michael Schulder (M)

Department of Neurosurgery, Zucker School of Medicine at Hofstra/Northwell, Lake Success, New York.

Classifications MeSH